As ANXA1 seems to be expressed differently across a range of cancers, and this expression also seems to vary depending on factors such as tumour stage and metastasis [117], the idea of developing this protein as a biomarker for all cancers could be seen as slightly challenging. The gene discussed is ANXA1; the disease is neoplasm.